Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Acceleron Pharma Inc. (XLRN)

« Back to company index

XLRN Chatter Timeline

Stock Ticker for XLRN

Most Active Tweeters for XLRN

UserTweets
@MarcJacksonLA 9
@FlashAlert_me 5
@EdgarInsider 3
@MarketCurrents 3
@stock_titan 3

Recent Tweets for XLRN

CSIMarket @CSIMarket
$XLRN #StockMarket #AcceleronPharma issued fiscal first quarter of 2021 Revenues on https://t.co/savSNTKlN1: XLRN a… https://t.co/gb7Lu02Juv
May 8th 2021, 8:05am
newsfilterio @newsfilterio
Acceleron Reports First Quarter 2021 Financial Results $XLRN https://t.co/xdH5PmZswL
May 8th 2021, 8:05am
SeekingAlpha @SeekingAlpha
$XLRN - Acceleron Pharma Inc. 2021 Q1 - Results - Earnings Call Presentation. https://t.co/ZYJp5ArnJ2 #markets #investing #finance
May 8th 2021, 6:05am
Biohazard3737 @Biohazard3737
Why is $XLRN -3%? People didn't like the Reblozyl royalty print? Or something else?
May 7th 2021, 6:05pm
SwingTradeBot @SwingTradeBot
200 DMA Support today: $XLRN ... https://t.co/LjP7KUcNnp
May 7th 2021, 6:05pm
MarcJacksonLA @MarcJacksonLA
$XLRN HC Wainwright Maintains Buy Rating On Acceleron Pharma, $168 PT https://t.co/kLlQsqZIEw
May 7th 2021, 3:05pm
EarningsAlley @EarningsAlley
Acceleron Pharma Inc. $XLRN held an earnings call on 5/6/2021. Here are the highlights:
May 7th 2021, 10:05am
newsfilterio @newsfilterio
Acceleron Pharma EPS beats by $0.07, misses on revenue $XLRN https://t.co/VZfKtFs4cM
May 7th 2021, 2:05am
Briefingcom @Briefingcom
$XLRN: Acceleron Pharma misses by $0.23, misses on revs, provides clinical update https://t.co/dr4D5ToORp
May 6th 2021, 10:05pm
AcceleronPharma @AcceleronPharma
Join our Q1 2021 webcast call now: https://t.co/36Y0XSm8Kc $XLRN https://t.co/OotErEFunA
May 6th 2021, 9:05pm
MarcJacksonLA @MarcJacksonLA
$XLRN Acceleron Reports First Quarter 2021 Financial Results https://t.co/3LAEaMtsdc via @tullahomanews
May 6th 2021, 9:05pm
MarketCurrents @MarketCurrents
$XLRN - Acceleron Pharma EPS beats by $0.07, misses on revenue https://t.co/lt361AO3U3
May 6th 2021, 8:05pm
ERCalendar @ERCalendar
Upcoming Earnings Report: $XLRN Acceleron Pharma Reporting on 05/06/2021 at 4:01 PM? Get Free Daily ER Calendar Sen… https://t.co/EGAUvk68j3
May 6th 2021, 8:05pm
Estimize @Estimize
$XLRN misses the Estimize EPS Consensus by 21c and beats the Estimize Revenue Consensus by $2.32M. Reports FQ1 earn… https://t.co/X7RPWIsmxk
May 6th 2021, 8:05pm
EdgarInsider @EdgarInsider
Filing for 10-Q [Quarterly Report] has been made with the SEC: $XLRN ACCELERON PHARMA INC https://t.co/Zouzo712Ue
May 6th 2021, 8:05pm
DojiTv @DojiTv
$XLRN Acceleron Pharma misses by $0.23, misses on revs, provides clinical update
May 6th 2021, 8:05pm
fintel_io @fintel_io
$XLRN / Acceleron Pharma files form 8-K - Financial Statements and Exhibits, Results of Operations and Financial Co… https://t.co/TkQUzwHpQV
May 6th 2021, 8:05pm
EdgarInsider @EdgarInsider
Filing Alert, FORM 8-K [Press/News Current Report] available. $XLRN ACCELERON PHARMA INC https://t.co/Jb85scVomu
May 6th 2021, 8:05pm
FlashAlert_me @FlashAlert_me
$XLRN [15s. delayed]: Issued Press Release on May 06, 16:01:00: Acceleron Reports First Quarter 2021 Financial Resu… https://t.co/zP3dLnoQJB
May 6th 2021, 8:05pm
FlashAlert_me @FlashAlert_me
$XLRN [15s. delayed] filed form 8-K on May 06, 16:04:29: Item2.02: Results of Operations & Financial Condition https://t.co/jQsWQAJAdz
May 6th 2021, 8:05pm
stock_titan @stock_titan
$XLRN Acceleron Reports First Quarter 2021 Financial Results https://t.co/lMzwfoqqzt
May 6th 2021, 8:05pm
StockPods @StockPods
$XLRN Earnings Call Today: 5:00 PM EST Webcast: https://t.co/CsKBtqaS3T Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99
May 6th 2021, 7:05pm
AccesswireNews @AccesswireNews
$XLRN Acceleron Pharma, Inc. to Host Earnings Call https://t.co/jTPD9jJTxa
May 6th 2021, 6:05pm
Tickeron @Tickeron
$XLRN reports Earnings today. $XLRN's price moved below its 50-day Moving Average on April 8, 2021. View odds for t… https://t.co/xeL5i5l5Ta
May 6th 2021, 4:05pm
Estimize @Estimize
$XLRN reports after the close, Estimize Consensus -0.08 EPS and +0.24M Revs compared to WS - https://t.co/ChxIo25e8t
May 6th 2021, 3:05pm
glitchbotio @glitchbotio
RT @MarketCurrents: $XLRN - Acceleron Pharma Q1 2021 Earnings Preview https://t.co/XNM0U37rga
May 5th 2021, 9:05pm
MarketCurrents @MarketCurrents
$XLRN - Acceleron Pharma Q1 2021 Earnings Preview https://t.co/XNM0U37rga
May 5th 2021, 9:05pm
MarcJacksonLA @MarcJacksonLA
$XLRN Acceleron Pharma Given Consensus Recommendation of "Buy" by Brokerages | $146.80 https://t.co/HLMcK93KBr https://t.co/UX1rbPSxBQ
May 5th 2021, 5:05pm
Tickeron @Tickeron
Acceleron Pharma Inc to report earnings on August 05, 2021. Earnings per share (EPS) estimate: $-0.64 $XLRN… https://t.co/dHtdQT6bZu
May 5th 2021, 2:05pm
PaulTorresCohen @PaulTorresCohen
Paul Torres-Cohen $XLRN
May 3rd 2021, 12:05pm
bearcapital1 @bearcapital1
$XLRN takeover inevitable IMO. Aside from PAH drug which will be a blockbuster they’ve been executing consistently… https://t.co/LzmpRYPjw3
April 30th 2021, 4:04pm
equity_newswire @equity_newswire
$XLRN Acceleron Announces First Quarter 2021 REBLOZYL® Net Sales https://t.co/RcW2YB16J4
April 30th 2021, 1:04am
MarcJacksonLA @MarcJacksonLA
$XLRN HC Wainwright Maintains Buy Rating On Acceleron Pharma, $168 PT https://t.co/FMt5F2SF6M
April 29th 2021, 11:04pm
BioPharmaDive @BioPharmaDive
FDA gives first citation to biotech for failure to report clinical trial details https://t.co/eD5lan4xuZ by Kristin Jensen $XLRN
April 29th 2021, 8:04pm
PearlF @PearlF
RT @JacobPlieth: Wow, FDA getting really tough here. Threatens action over clinical data for a drug $XLRN had discontinued 4 years ago! htt…
April 29th 2021, 8:04pm
WilliamGerber1 @WilliamGerber1
RT @JacobPlieth: Woodcock guns for $XLRN's discontinued project, so that leaves just 24,655 more with no summary results to go! Via @evalua…
April 29th 2021, 7:04pm
YuZhu4 @YuZhu4
RT @JacobPlieth: Wow, FDA getting really tough here. Threatens action over clinical data for a drug $XLRN had discontinued 4 years ago!
April 29th 2021, 7:04pm
BentheFidler @BentheFidler
FDA gives first citation to biotech for failure to report clinical trial details https://t.co/JtqicJvSfw by Kristin Jensen $XLRN
April 29th 2021, 3:04pm
MarcJacksonLA @MarcJacksonLA
$XLRN Acceleron Finds Itself in FDA's Crosshairs After Failure to Post Clinical Data Summary | BioSpace https://t.co/lIewfAIBKl #jobs
April 29th 2021, 3:04pm
JacobPlieth @JacobPlieth
Woodcock guns for $XLRN's discontinued project, so that leaves just 24,655 more with no summary results to go! Via… https://t.co/FNzQrr5hDs
April 29th 2021, 2:04pm
otcdynamics @otcdynamics
$XLRN Acceleron Announces First Quarter 2021 REBLOZYL® Net Sales https://t.co/ENSbVFarbk
April 29th 2021, 11:04am
EdgarInsider @EdgarInsider
FORM 8-K [Press/News Current Report] recently SEC filed. $XLRN ACCELERON PHARMA INC https://t.co/zfNkafORTN
April 29th 2021, 11:04am
fintel_io @fintel_io
$XLRN / Acceleron Pharma files form 8-K - Results of Operations and Financial Condition - 8-K https://t.co/VfqOU0xVtG
April 29th 2021, 11:04am
FlashAlert_me @FlashAlert_me
$XLRN [15s. delayed] filed form 8-K on April 29, 07:24:20: Item2.02: Results of Operations & Financial Condition https://t.co/uPTAFrM1lQ
April 29th 2021, 11:04am
FlashAlert_me @FlashAlert_me
$XLRN [15s. delayed]: Issued Press Release on April 29, 07:10:00: Acceleron Announces First Quarter 2021 REBLOZYL®… https://t.co/NFNszfpk18
April 29th 2021, 11:04am
AcceleronPharma @AcceleronPharma
$XLRN announces Q1 2021 REBLOZYL (luspatercept-aamt) #netsales. For more info, click here: https://t.co/Rp5gAFTwdb
April 29th 2021, 11:04am
stock_titan @stock_titan
$XLRN Acceleron Announces First Quarter 2021 REBLOZYL® Net Sales https://t.co/74BCxcWlv6
April 29th 2021, 11:04am
JacobPlieth @JacobPlieth
Wow, FDA getting really tough here. Threatens action over clinical data for a drug $XLRN had discontinued 4 years a… https://t.co/yL7SQOVn4S
April 29th 2021, 8:04am
christymaginn @christymaginn
RT @bradloncar: FDA calls out $XLRN for failing to submit clinical trial results info to https://t.co/yglMSbNpm7. First time FDA has done t…
April 29th 2021, 3:04am
glitchbotio @glitchbotio
RT @MarketCurrents: $XLRN - In a first, FDA cites Acceleron for not submitting trial results to https://t.co/3MWKa12OT0 https://t.co/8TpntC…
April 28th 2021, 8:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.